PNPLA3 G allele carriers in NAFLD patients exhibit more severe forms of the disease, and the prevalence of advanced liver fibrosis, cirrhosis, and HCC is higher among them. This evidence concerns the gene PNPLA3 and hepatocellular carcinoma.